Gapping up
In reaction to strong earnings/guidance:
- SECO +7.3%
M&A news:
- FMI +28% (to be acquired by Roche (RHHBY) for $137/share)
- PENN +1% (to acquire operations of Margaritaville Resort Casino for $115M in cash)
Other news:
- NEPT +33.5% (enters into a multi-year agreement with Canopy Growth; Neptune will supplement Canopy Growth's extraction, refinement, and extract product formulation capacity)
- VIVE +8.4% (reports 'positive' six-month data from stress urinary incontinence feasibility study; to host call on June 19 at 8am ET)
- NCMI +5.3% (Cinemark and Cineworld announce agreement to purchase remaining units of National CineMedia held by AMC Entertainment Holdings (AMC) for $156.8 mln)
- NEW +2.7% (continued momentum in recent IPO)
- CLPS +1.9% (continued momentum in recent IPO)
- ACAD +1.1% (Point72 increases passive stake)
- BHVN +1% (Royalty Pharma acquires 2% royalty rights on global annual net sales of rimegepant and BHV-3500; Royalty Pharma agrees to acquire 1,111,111 Biohaven common shares for $45.00 per share)
Analyst comments:
- BLUE +1.2% (upgraded to Outperform from In-line at Evercore ISI)
- VZ +0.5% (upgraded to Buy from Hold at Deutsche Bank)